When Should an Eyelid Lesion Be Biopsied?

Patients who have a lid bump that will not go away, or who have been told they might need a biopsy, want to understand when that step is truly necessary and when it is safe to simply watch. Some have had a lesion removed before that came back; others have treated a presumed stye for weeks without success. They are trying to gauge how worried to be and whether cutting into the lid is really needed.

A biopsy is how an eye doctor moves from suspicion to certainty. Many eyelid bumps are clearly benign on examination and need no biopsy, but some cannot be confidently diagnosed by looking alone — and a few benign-appearing lesions are actually cancer in disguise. Sampling the tissue lets a pathologist determine exactly what the lesion is.

This matters because eyelid cancers behave very differently from benign bumps: they grow, damage the lid, and, if missed, become harder to treat. A well-timed biopsy either provides reassurance that the lesion is harmless or identifies a cancer early, when removal is simpler and the eyelid and the eye's function can be preserved.

The decision to biopsy rests on the lesion's features and behavior. Concerning findings include ulceration or a sore that will not heal, spontaneous or easy bleeding, loss of eyelashes over the lesion (madarosis), irregular, asymmetric, pearly, or rolled borders, fine surface vessels, pigment changes, distortion of the lid margin, and — importantly — growth, change, or recurrence after removal. Any one strong feature, or a combination, tips the balance toward biopsy.

Certain scenarios specifically prompt biopsy even when a lesion looks ordinary. A chalazion that recurs in the same location or fails to resolve with standard treatment can be sebaceous carcinoma masquerading as a benign cyst. Likewise, chronic, one-sided lid-margin inflammation that behaves like blepharitis or conjunctivitis but does not respond should be biopsied, because sebaceous carcinoma can present this way (sometimes called masquerade syndrome). The three main eyelid cancers — basal cell (most common), squamous cell, and the aggressive sebaceous carcinoma — can overlap in appearance with benign lesions, so histology is the definitive arbiter. The biopsy may be incisional, taking a sample from a larger or margin-critical lesion, or excisional, removing the whole lesion; the tissue is then examined microscopically, and margins are assessed if cancer is found.

The lesions that most need biopsy are exactly the serious-looking ones:

• Bleeding, ulceration, or a non-healing sore
• Loss of eyelashes at the site
• Irregular, asymmetric, or pearly borders, or a distorted lid margin
• Growth, color change, or recurrence after prior removal
• A chalazion that keeps recurring or will not resolve
• Chronic one-sided lid inflammation that resists treatment

Any of these should be evaluated promptly and biopsied rather than watched indefinitely.

The doctor examines the lesion under the slit lamp, characterizing its borders, surface, vessels, pigment, lash involvement, and any lid-margin distortion, and reviews the history of growth, bleeding, or recurrence. If the lesion is a classic benign entity behaving typically, observation or routine treatment is reasonable. If the features are suspicious or the diagnosis is uncertain, the doctor performs a biopsy — sampling or fully removing the lesion — and sends it for pathology. When cancer is confirmed, margins are checked (often with a margin-controlled technique) and the extent of the tumor is assessed to plan complete removal and lid reconstruction, with referral to an oculoplastic specialist as needed.

The biopsy itself guides everything that follows. If pathology shows a benign lesion, no further cancer treatment is needed and any bothersome bump can simply be removed. If it shows cancer, treatment is tailored to the type and size: most eyelid skin cancers are removed surgically with margin control (such as Mohs surgery) to ensure complete excision while preserving as much healthy lid as possible, followed by reconstruction. More aggressive tumors, particularly sebaceous carcinoma, may require wider excision, additional staging, and sometimes adjunctive treatment or specialist referral. Because the biopsy establishes the diagnosis, it is the pivotal step that makes the right treatment possible.

• Do not keep treating a recurrent or non-healing "chalazion" indefinitely without a biopsy.
• Do not assume a lesion is benign just because it is small or painless; some cancers are both.
• Do not pick at, squeeze, or attempt to remove a suspicious lid lesion yourself.
• Do not ignore a lesion that bleeds, ulcerates, loses lashes, or recurs after removal.
• Do not delay biopsy out of fear — early diagnosis makes treatment simpler and outcomes better.

Call May Eye Care Center if you have an eyelid lesion that bleeds, ulcerates, loses eyelashes, distorts the lid, recurs, or will not heal, or a chalazion that keeps coming back, so it can be examined and biopsied if warranted. Chronic one-sided lid inflammation that resists treatment also deserves evaluation. Patients across the Hanover area are welcome to schedule a visit rather than watching a suspicious lesion at home.

An eyelid lesion should be biopsied when it bleeds, ulcerates, loses eyelashes, has irregular borders, or grows or recurs — including a stubborn chalazion or persistent one-sided lid inflammation — because the biopsy confirms whether it is benign or an early, treatable cancer.